Mammolink

MammoLink is building the future of breast cancer screening at national scale. We combine advanced imaging, precision operations, and intelligent technology to deliver high-quality breast cancer screening and diagnosis to Fortune 500 companies, government agencies, and healthcare systems. Our model removes friction, reduces costs, and expands access—aligning corporate, governmental, and healthcare strategy with meaningful, measurable improvement in outcomes. Our partnerships position MammoLink as one of the nations most scalable public–private screening solutions. At the state level, we are actively engaged with congressional leaders to advance policies that strengthen coverage for supplemental and mobile breast imaging—critical to improving the present and future screening process. We serve major employers including Walmart, Amazon, Costco, and others by delivering turnkey screening programs that boost participation, streamline compliance, and reduce downstream oncology costs. Our custom-engineered mobile units feature state of the art communications, Hologic 3D tomosynthesis, breast ultrasound, same-day expert reads, and a patient-first environment designed to elevate the screening experience and remove behavioral barriers. Our technology ecosystem is built for scale. From our phone-based patient app to AI-assisted scheduling, routing, analytics, and follow-up, we optimize efficiency across every step of the screening pathway—ensuring consistency, accuracy, and throughput at volumes well beyond traditional imaging centers. Through Think Pink Project Inc, our nonprofit arm, we further expand access for underserved and financially vulnerable communities, reinforcing our commitment to health equity and corporate social responsibility. MammoLink is rapidly growing, operationally disciplined, and strategically positioned for multi-state and national expansion. We deliver early detection as a service—scalable, efficient, and measurable.